Oscar Health, Inc. (OSCR) Quick Ratio
- Quick ratio · latest quarter: Value 1.03×; Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | 1.03× | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. $8.94B ÷ $8.69B ≈ 1.03× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | 8.94B USD | Cash and Cash Equivalents, at Carrying Value · Debt Securities, Available-for-sale, Current · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 8.69B USD | Liabilities, Current |
| Cash and equivalents | 4.08B USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | 4.48B USD | Debt Securities, Available-for-sale, Current |
| Customer receivables | 380.06M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $8.94B | $8.69B | $4.08B | $4.48B | $380.06M | (m) | 1.03× |
| 2026-03-31 | $7.39B | $7.14B | $4.81B | $1.99B | $587.02M | (m) | 1.03× |
| 2025-12-31 | (m) | $4.86B | $2.77B | $1.22B | (m) | (m) | (m) |
| 2025-09-30 | (m) | $3.98B | $2.15B | $887.59M | (m) | (m) | (m) |
| 2025-06-30 | (m) | $4.87B | $2.60B | $938.10M | (m) | (m) | (m) |
| 2025-03-31 | (m) | $4.15B | $2.24B | $751.49M | (m) | (m) | (m) |
| 2024-12-31 | (m) | $3.46B | $1.53B | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $2.95B | $1.21B | $503.78M | (m) | (m) | (m) |
| 2024-06-30 | (m) | $3.50B | $2.27B | $363.64M | (m) | (m) | (m) |
| 2024-03-31 | (m) | $3.02B | $2.23B | $616.13M | (m) | (m) | (m) |
| 2023-12-31 | (m) | $2.43B | $1.87B | $689.83M | (m) | (m) | (m) |
| 2023-09-30 | (m) | $2.06B | $1.40B | $1.04B | (m) | (m) | (m) |
| 2023-06-30 | (m) | $3.24B | $2.32B | $1.26B | (m) | (m) | (m) |
| 2023-03-31 | (m) | $3.18B | $2.11B | $1.32B | (m) | (m) | (m) |
| 2022-12-31 | (m) | $3.26B | $1.56B | $1.40B | (m) | (m) | (m) |
| 2022-09-30 | (m) | $2.85B | $2.11B | $718.23M | (m) | (m) | (m) |
| 2022-06-30 | (m) | $3.13B | $2.36B | $909.01M | (m) | (m) | (m) |
| 2022-03-31 | (m) | $2.64B | $2.07B | $810.00M | (m) | (m) | (m) |
| 2021-12-31 | (m) | $1.85B | $1.10B | $587.09M | (m) | (m) | (m) |
| 2021-09-30 | (m) | $1.62B | $1.08B | $586.95M | (m) | (m) | (m) |
| 2021-06-30 | (m) | $1.97B | $1.67B | $614.98M | (m) | (m) | (m) |
| 2021-03-31 | (m) | $1.81B | $2.32B | $389.02M | (m) | (m) | (m) |
| 2020-12-31 | (m) | $1.67B | $826.33M | $366.39M | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | $337.41M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | $988.53M | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | $491.71M | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $336.64M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.